Reactivity of murine and human recombinant LPS-binding protein (LBP) within LPS and gram negative bacteria

S Lengacher1, C V Jongeneel, D Le Roy

  • 1Division of Infectious Diseases, CHUV, Laussane, Switzerland.

Journal of Inflammation
|January 1, 1995
PubMed

Insights

Serum lipopolysaccharide (LPS) binding protein (LBP) enhances cellular responses to LPS. Recombinant LBP binds avidly to free LPS and heat-killed bacteria, but weakly to live Gram-negative bacteria.

Area of Science:

  • Immunology
  • Microbiology
  • Biochemistry

Background:

  • Serum lipopolysaccharide (LPS) binding protein (LBP) significantly amplifies cellular reactions to low LPS concentrations.
  • LBP facilitates LPS transfer to CD14, initiating signaling cascades in susceptible cells.

Purpose of the Study:

  • To clone and sequence murine LBP cDNA.
  • To produce recombinant murine LBP using a baculovirus expression system.
  • To investigate the binding characteristics of recombinant LBP to LPS and bacteria.

Main Methods:

  • Cloning and sequencing of murine LBP cDNA.
  • Production of recombinant murine LBP via baculovirus expression.
  • Solid-phase and cytofluorometric assays to assess LBP binding to LPS and bacteria.

Main Results:

  • Recombinant murine and human LBP exhibit avid binding to free LPS.
  • LBP binds weakly to live Gram-negative bacteria, with binding loosely correlating to O chain length and composition.
  • Recombinant LBP demonstrates strong binding to heat-killed Gram-negative bacterial preparations.

Conclusions:

  • LBP's binding affinity differs significantly between live and killed Gram-negative bacteria.
  • Findings suggest LBP's primary role in immune response may be directed towards killed, rather than live, Gram-negative bacteria.